Company Overview and News
The Indian benchmark indices including the Nifty is trading lower by 36 points at 10,981 while the Sensex is down 67 points at 36,474.
PWQFY 500325 BRTQY TCHQY FEDA TTQQY JISLJALEQS 532514 ASIANPAINT 532755 TATACHEM 539437 IGL JUSTDIAL AMBUY 532482 FEDS 500696 CUMMINSIND BJJQY 500570 BRITANNIA FEDERALBNK 500770 SUNTV RLNIY 500219 BPCL RELCAPITAL 524804 532706 CANFINHOME FDBAY 511196 532548 530005 TECHM BAJAJFINSV BAJFINANCE TATASTEEL TATLY BRQPY KOTAKBANK 534809 500103 PCJEWELLER ANDHRABANK 500825 500820 532939 AUROPHARMA 500425 500469 500547 RELIANCE KTKBANK 532418 INOXLEISUR HINDUNILVR 532978 532810 532733 AMBUJACEM CMQMY GRANULES 500470 535648 IDFCBANK CENTURYPLY RIGD INDIACEM TATAMOTORS 500034 500111 RPOWER 570004 UBNC KMBKY IBN BHEL PFC 532652 500480 ICICIBANK TTST 532174 JISLDVREQS ARBQY BRHTY 500247 SNQVY JSTQY TTM
Share prices of oil marketing and aviation companies rallied 4-6 percent intraday on Thursday following the sharp correction in crude oil prices in the international markets.
IOC INDIGO BPCL 500547 BRQPY 532617 HINDPETRO JETAIRWAYS 530965 500104 539448
Reliance Industries (RIL), Aegis Logistics, GAIL and Gujarat Gas rallied 2-4 percent intraday on Tuesday as the bidding for the ninth round of City Gas Distribution Scheme closes later today.
IOC 500325 BPCL 500547 RELIANCE 539336 AEGISLOG 530965 532514 IGL GUJGAS BRQPY RIGD GAILY 500003 HINDPETRO GAILF 500104 RLNIY
LONDON (July 6): Asian spot liquefied natural gas (LNG) prices declined for a third week on producers from Australia to Nigeria boosting spot supply, strong European LNG inventories and Pakistan's cancellation of a six-cargo tender.
CQP BPCL 500547 BRQPY LNG
Mumbai: State-owned fuel marketers are pushing back against a regulatory suggestion to allow Reliance Industries Ltd (RIL) to use their pipelines to sell jet fuel at the Mumbai airport.
IOC 500325 BPCL 500547 BRQPY RELIANCE RIGD HINDPETRO 530965 500104 RLNIY
LONDON, July 7 — Asian spot liquefied natural gas (LNG) prices declined for a third week on producers from Australia to Nigeria boosting spot supply, strong European LNG inventories and Pakistan’s cancellation of a six-cargo tender.
CQP BPCL 500547 BRQPY LNG
SINGAPORE (Reuters) - Sellers of U.S. sour crude oil have cut their offers for Asian buyers on concern that demand may fall as China threatens to impose tariffs on oil from the United States and Middle East supply may rise after major producers agreed to increase output, multiple trade sources said on Wednesday.
BPCL 500547 BRQPY
SINGAPORE, July 4 (Reuters) - Sellers of U.S. sour crude oil have cut their offers for Asian buyers on concern that demand may fall as China threatens to impose tariffs on oil from the United States and Middle East supply may rise after major producers agreed to increase output, multiple trade sources said on Wednesday.
BPCL 500547 BRQPY
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
IOC 5017 BPCL 500547 BRQPY 530965 5020
The Nifty and the Sensex are trading on a positive note this Tuesday afternoon after a flat morning session with the Nifty up 35 points at 10,797 and the Sensex is trading higher by 120 points at 35,591.
GRASIM 500408 500325 BRTQY JISLJALEQS ICLQY UCLQY 532480 BJJQY 500570 BRITANNIA CLNDY RLNIY ASHOKLEY SBAZ 500219 GRSJY BPCL TVSMOTOR UNITDSPR ALBK APOLLOTYRE AYRQY 530005 532822 517334 ULTRACEMCO AKLD 532432 BAJFINANCE BATAINDIA BRQPY UQNTY 500300 534809 HINDPETRO PCJEWELLER 500104 COALINDIA AKLS ABBOTINDIA 500825 500547 PQRTY RELIANCE PUNJLLOYD 512573 532538 533155 BHRQY NAUKRI JUBLFOOD 533278 532777 532343 MOZTY 532461 RIGD JBLWY 500477 INDIACEM BHARTIARTL TATAMOTORS 500034 570004 UBNC HINDALCO AVANTI 500877 UCLQF PETRONET 532522 532454 HNDNF GRSXY PNJZY 532693 MOTHERSUMI JISLDVREQS IDEA TATAELXSI PNB 500488 500043 500440 TTM
New Delhi : Abu Dhabi National Oil Company (Adnoc) on Monday signed an initial pact to take a stake in the planned $44-billion refinery in Maharashtra, joining Saudi Aramco which is looking at the project as a vehicle to enter India’s entire energy “value chain” including fuel retailing.
IOC BPCL 500547 BRQPY HINDPETRO 530965 500104
10h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
11h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...